NCT03841747 2024-03-12
PELICAN
Queen Mary University of London
Phase 2 Withdrawn
Clinical Trials
5 trialsNCT04602117 2023-11-18
ISPY-P1.01:Evaluating the Safety of Weekly Paclitaxel With Trastuzumab Duocarmazine (SYD985) in Patients With Metastatic Cancer
QuantumLeap Healthcare Collaborative
Phase 1 Withdrawn
NCT02929576 2018-10-22
ENDEAR
Pfizer
Phase 3 Withdrawn
NCT02274012 2017-03-14
Trial of Afatinib in Combination With Weekly Paclitaxel in the Second Line Treatment
Columbia University
Phase 2 Withdrawn
NCT01169870 2012-01-04
Genexol-PM Versus Paclitaxel in Anthracycline-pretreated Metastatic Breast Cancer Patients
National Cancer Center, Korea
Phase 2 Withdrawn